Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Tirzepatide

    Virtual Booth

    Contact Supplier

    Tirzepatide

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Tirzepatide

    Virtual Booth

    Contact Supplier

    Tirzepatide

    Virtual Booth

    Contact Supplier

    Menu

    Tirzepatide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 472,403Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 175Eli Lilly

    02 2ORIFARM GROUP AS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO (AUTOINJECTOR)

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

    Packaging :

    Approval Date : 2022-05-13

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO (AUTOINJECTOR)

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

    Packaging :

    Approval Date : 2022-05-13

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO (AUTOINJECTOR)

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

    Packaging :

    Approval Date : 2022-05-13

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO (AUTOINJECTOR)

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

    Packaging :

    Approval Date : 2022-05-13

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO (AUTOINJECTOR)

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

    Packaging :

    Approval Date : 2022-05-13

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO (AUTOINJECTOR)

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

    Packaging :

    Approval Date : 2022-05-13

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

    Packaging :

    Approval Date : 2023-07-28

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

    Packaging :

    Approval Date : 2023-07-28

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

    Packaging :

    Approval Date : 2023-07-28

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

    Packaging :

    Approval Date : 2023-07-28

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

    Packaging :

    Approval Date : 2023-07-28

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

    Packaging :

    Approval Date : 2023-07-28

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 10MG/2.4ML (4.17MG/ML)

    Packaging :

    Approval Date : 2026-01-07

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 20MG/2.4ML (8.33MG/ML)

    Packaging :

    Approval Date : 2026-01-07

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 30MG/2.4ML (12.5MG/ML)

    Packaging :

    Approval Date : 2026-01-07

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 40MG/2.4ML (16.7MG/ML)

    Packaging :

    Approval Date : 2026-01-07

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 50MG/2.4ML (20.8MG/ML)

    Packaging :

    Approval Date : 2026-01-07

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 60MG/2.4ML (25MG/ML)

    Packaging :

    Approval Date : 2026-01-07

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO KWIKPEN

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 10MG/2.4ML (4.17MG/ML)

    Packaging :

    Approval Date : 2026-01-20

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Eli Lilly

    U.S.A
    BIO CEO & Investor
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    TIRZEPATIDE

    Brand Name : MOUNJARO KWIKPEN

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 20MG/2.4ML (8.33MG/ML)

    Packaging :

    Approval Date : 2026-01-20

    Application Number : 215866

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.